Skip to main content
Caplight Logo









Precisis GmbH

Precisis GmbH

Private
HeidelbergHealthcare & Life Scienceshttps://precisis.de/

Last Round

Debt

Oct 30, 2025

Total Funding Raised

$47.3M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Precisis GmbH is a medical technology company that develops minimally invasive neurostimulation therapies for neurological disorders, including its flagship EASEE® brain pacemaker for drug-resistant focal epilepsy.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

epilepsy treatmentneurostimulationneuromodulationfocal epilepsy treatmentminimally invasive therapyimplantable medical devicebioelectronic medicineepicranial stimulationdrug-resistant epilepsybrain pacemakerEASEE systemDBS alternativeVNS alternative

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Precisis GmbH Comparables

Compare Precisis GmbH with similar companies based on industry and business-model similarity.

Precisis GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cadence Neuroscience
83%
NeuroPace
77%
LivaNova
77%

Precisis GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtOct 30, 2025
Series BOct 30, 2025
GrantDec 21, 2022
VC RoundOct 20, 2021

Key People

Founding team and executive leadership

Karl Stoklosa

Chief Executive Officer

Executive Team

Michael Tittelbach

Managing Director And CTO

Executive Team

Precisis GmbH Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 8, 2025

    Monthly visitors increased 78% MoM.

  • Oct 30, 2025

    Completed a Series B funding round.

Precisis GmbH Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Precisis GmbH Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Precisis GmbH's valuation, stock price, and market status.

Firmographic Details

HeadquartersHeidelberg
Employee Range45
Year Founded2014
Last FundingOct 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?